logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hideki Iwamoto

Kurume University School of Medicine
H指数:39
被引数:5,439

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab

durvalumab联合tremelimumab治疗肝细胞癌患者淋巴细胞计数早期变化可预测临床结局

Journal of Gastroenterology and Hepatology
IF3.4
2026-10-070
OAAI
Yuichi Honma; Shigeo Shimose; Takanori Ito; Issei Saeki; Joji Tani; Takanori Matsuura; Tetsu Tomonari; Yasuto Takeuchi; Nobuhito Taniki; Kyo Sasaki; Ryu Sasaki; Takeshi Hatanaka; Satoru Kakizaki; Naoki Yoshioka; Takehito Naito; Mamiko Takeuchi; Tetsuya Yasunaka; Masahiro Sakata; Hideki Iwamoto; Tomotake Shirono; Satoshi Itano; Norikazu Tanabe; Takafumi Yamamoto; Atsushi Naganuma; Yuki Kanayama; Hisamitsu Miyaaki; Sohji Nishina; Nobuhiro Nakamoto; Motoyuki Otsuka; Tetsuji Takayama; Yuzo Kodama; Hideki Kobara; Taro Takami; Hiroki Kawashima; Takumi Kawaguchi; Masaru Harada
Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case Report

恶性肝细胞肿瘤（Not Otherwise Specified）经新FP疗法后行转化性肝切除术：一例病例报告

Hepatology Research
IF3.4
2026-02-240
PRE
Etsuko Moriyama; Hironori Koga; Takashi Niizeki; Hideki Iwamoto; Shigeo Shimose; Tomotake Shirono; Takahiko Tokushige; Masahito Nakano; Ryoko Kuromatsu; Toru Goto; Masaki Honda; Taizo Hibi; Yoshiki Mikami; Reiichiro Kondo; Jun Akiba; Takumi Kawaguchi
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B

阿特珠单抗联合贝伐珠单抗在Child-Pugh B级肝细胞癌患者中的有效性与安全性

LIVER INTERNATIONAL
IF5.2
2025-11-280
OAAI
Sasaki, Ryu; Shimose, Shigeo; Saeki, Issei; Ito, Takanori; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Miuma, Satoshi; Shirono, Tomotake; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Kanayama, Yuki; Naganuma, Atsushi; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Kawashima, Hiroki; Takami, Taro; Kawaguchi, Takumi; Miyaaki, Hisamitsu
Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

不可切除肝细胞癌患者接受阿特珠单抗联合贝伐珠单抗治疗后序贯免疫检查点抑制剂再治疗的结局

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
IF3.4
2025-11-010
OAAI
Ito, Takanori; Shimose, Shigeo; Saeki, Issei; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Ryu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Shirono, Tomotake; Kanayama, Yuki; Miyaaki, Hisamitsu; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Takami, Taro; Kawaguchi, Takumi; Kawashima, Hiroki
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study

代谢相关脂肪性肝病与度伐利尤单抗和特瑞普利单抗在晚期肝细胞癌患者临床结局中的关联：一项多中心研究

Hepatology Research
IF3.4
2025-08-210
PRE
Takeshi Hatanaka; Shigeo Shimose; Takanori Ito; Joji Tani; Tetsu Tomonari; Issei Saeki; Yasuto Takeuchi; Kyo Sasaki; Yuichi Honma; Ryu Sasaki; Naoki Yoshioka; Takehito Naito; Mamiko Takeuchi; Tetsuya Yasunaka; Masahiro Sakata; Hideki Iwamoto; Satoshi Itano; Yuki Kanayama; Tomotake Shirono; Norikazu Tanabe; Takafumi Yamamoto; Atsushi Naganuma; Sohji Nishina; Motoyuki Otsuka; Hideki Kobara; Taro Takami; Tetsuji Takayama; Takumi Kawaguchi; Hiroki Kawashima; Masaru Harada; Hisamitsu Miyaaki; Satoru Kakizaki; Hepatology InVestigator Experts in Japan (HIVE-J) Study Group
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma
BMC CANCER
IF3.4
2025-03-110
OAAI
Kodama, Yoshihisa; Ueshima, Kazuomi; Moriguchi, Michihisa; Inaba, Yoshitaka; Yamashita, Tatsuya; Iwamoto, Hideki; Ueno, Makoto; Ogasawara, Sadahisa; Kuzuya, Teiji; Kodama, Takahiro; Sato, Yozo; Tada, Toshifumi; Tsuchiya, Kaoru; Nishiofuku, Hideyuki; Yamakado, Koichiro; Sone, Miyuki; Ikeda, Masafumi; Takehara, Tetsuo; Hamano, Tetsutaro; Kudo, Masatoshi
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
HEPATOLOGY INTERNATIONAL
IF6.1
2025-02-280
PRE
Shimose, Shigeo; Saeki, Issei; Ito, Takanori; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Ryu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Shirono, Tomotake; Kanayama, Yuki; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Kawashima, Hiroki; Takami, Taro; Kawaguchi, Takumi; Hepatology InVestigator Experts Japan HIVE-J Study Grp
Antitumor effects and immune-mediated adverse events of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma

durvalumab联合tremelimumab治疗不可切除的肝细胞癌的抗肿瘤作用和免疫介导的不良事件

HEPATOLOGY RESEARCH
IF3.4
2024-12-150
OA
Ito, Takanori; Shimose, Shigeo; Tani, Joji; Tomonari, Tetsu; Saeki, Issei; Takeuchi, Yasuto; Hatanaka, Takeshi; Sasaki, Kyo; Kakizaki, Satoru; Kanayama, Yuki; Yoshioka, Naoki; Naito, Takehito; Takeuchi, Mamiko; Yasunaka, Tetsuya; Sakata, Masahiro; Iwamoto, Hideki; Itano, Satoshi; Shirono, Tomotake; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Nishina, Sohji; Otsuka, Motoyuki; Takami, Taro; Takayama, Tetsuji; Kawaguchi, Takumi; Kawashima, Hiroki
Hepatic arterial infusion of autologous CD34+cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial
REGENERATIVE THERAPY
IF3.5
2024-12-012
OAAI
Nakamura, Toru; Masuda, Atsutaka; Kako, Makoto; Enomoto, Hirayuki; Kaibori, Masaki; Fujita, Yasuyuki; Tanizawa, Kyoko; Ioji, Tetsuya; Fujimori, Yoshihiro; Fukami, Kei; Hazama, Takuma; Iwamoto, Hideki; Kako, Yasukazu; Kobayashi, Kaoru; Koga, Hironori; Nagafuji, Koji; Ohtake, Takayasu; Suzuki, Hiroyuki; Takashima, Tomoyuki; Tsukiyama, Toshitaka; Uojima, Haruki; Yamahara, Kenichi; Yamakado, Koichiro; Yamamoto, Hidekazu; Yoh, Kazunori; Yoshihara, Satoshi; Kawamoto, Atsuhiko; Nishiguchi, Shuhei; Kobayashi, Shuzo; Torimura, Takuji; Kawaguchi, Takumi
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab
SCIENTIFIC REPORTS
IF3.9
2024-08-301
OAAI
Rimini, Margherita; Montes, Margarida; Amadeo, Elisabeth; Vitiello, Francesco; Kudo, Masatoshi; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Lonardi, Sara; Finkelmeier, Fabian; Salani, Francesca; Antonuzzo, Lorenzo; Marra, Fabio; Iavarone, Massimo; Cabibbo, Giuseppe; Foschi, Francesco Giuseppe; Silletta, Marianna; Sacco, Rodolfo; Rapposelli, Ilario Giovanni; Scartozzi, Mario; Nicoletta, Pella; Aldrighetti, Luca; Persano, Mara; Camera, Silvia; Rossari, Federico; Foti, Silvia; Kumada, Takashi; Hiraoka, Atsushi; Iwamoto, Hideki; Rizzato, Mario Domenico; Himmelsbach, Vera; Masi, Gianluca; Corradi, Mattia; Celsa, Ciro; Fabio, Conti; Frassineti, Giovanni Luca; Cascinu, Stefano; Casadei-Gardini, Andrea; Presa, Jose
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab

不良事件是晚期HCC患者接受阿特珠单抗联合贝伐单抗治疗的潜在预测因素

TARGETED ONCOLOGY
IF4
2024-04-301
OAAI
Persano, Mara; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Rossari, Federico; Yoo, Changhoon; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Bergamo, Francesca; Amadeo, Elisabeth; Vitiello, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Iavarone, Massimo Alberto; Cabibbo, Giuseppe; Montes, Margarida; Foschi, Francesco Giuseppe; Vivaldi, Caterina; Solda, Caterina; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Bruccoleri, Mariangela; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Hiraoka, Atsushi; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Foti, Silvia; Camera, Silvia; Piscaglia, Fabio; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea
Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study
LIVER CANCER
IF9.1
2024-04-106
OAAI
Rossari, Federico; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Yoo, Changhoon; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Bergamo, Francesca; Amadeo, Elisabeth; Vitiello, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Iavarone, Massimo; Cabibbo, Giuseppe; Montes, Margarida; Foschi, Francesco Giuseppe; Vivaldi, Caterina; Solda, Caterina; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Hiraoka, Atsushi; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaaki; Iijima, Hiroko; Hiasa, Yoichi; Persano, Mara; Foti, Silvia; Camera, Silvia; Stefanini, Bernardo; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea; Rimini, Margherita
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab

体重指数对接受一线乐伐替尼或阿特珠单抗联合贝伐单抗治疗的不可切除HCC患者预后的影响

LIVER INTERNATIONAL
IF5.2
2024-03-222
PRE
Rimini, Margherita; Stefanini, Bernardo; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Finkelmeier, Fabian; Yoo, Changhoon; Presa, Jose; Amadeo, Elisabeth; Genovesi, Virginia; De Grandis, Maria Caterina; Iavarone, Massimo; Marra, Fabio; Foschi, Francesco; Tamburini, Emiliano; Rossari, Federico; Vitiello, Francesco; Bartalini, Linda; Solda, Caterina; Tovoli, Francesco; Vivaldi, Caterina; Lonardi, Sara; Silletta, Marianna; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Himmelsbach, Vera; Montes, Margarida; Hiraoka, Atsushi; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Persano, Mara; Camera, Silvia; Foti, Silvia; Aldrighetti, Luca; Cascinu, Stefano; Casadei-Gardini, Andrea; Piscaglia, Fabio

研究方向

暂未获取到该数据
S
Shigeo Shimose
H 指数:28论文数:138被引数:2,238
T
Takuji Torimura
H 指数:58论文数:471被引数:1.3万
H
Hironori Koga
H 指数:47论文数:258被引数:8,689
T
Takumi Kawaguchi
H 指数:61论文数:514被引数:2.4万
T
Takashi Niizeki
H 指数:31论文数:153被引数:2,493
T
Tomotake Shirono
H 指数:21论文数:79被引数:1,361
M
Masahito Nakano
H 指数:25论文数:102被引数:1,971
A
Atsushi Hiraoka
H 指数:49论文数:543被引数:1.0万
T
Tõru Nakamura
H 指数:44论文数:463被引数:8,052
T
Toshifumi Tada
H 指数:54论文数:455被引数:1.3万